EIF4EBP1 and cancer: Besides, allosteric mTORi can modestly reduce p4E-BP1 levels through the inhibition of (4E-BP1) phosphorylation, and consequently, cannot effectively restrain eIF4E-mediated cap-dependent translation initiation in cancer [161].